Medical Publishing Insights and Practices (MPIP) initiative members share perspectives on the benefits of publishing industry-sponsored research open access.
Slávka Baróniková shares her opinions on open access publishing and suggests how this can be successfully achieved within pharma.
cOAlition S Rights Retention Strategy aims to safeguard researchers’ intellectual ownership, enabling embargo-free sharing of research in online repositories.
Tim Ellison, Senior Medical Writer at Oxford PharmaGenesis, discusses a study into the open access policies of leading medical journals
The Wellcome Trust announces a new open access policy, which includes five key updates.
In a recent MAP newsletter, ISMPP share an update from ASCO on their new open access option for industry-funded research.
Missed the 14th Annual Meeting of ISMPP? Read the second part of our meeting report to get up to speed!
A study finds that the most common form of open access is ‘bronze’, meaning that data are free to read but not re-use. This is likely to have negative implications for research.